Why Generation Bio Shares Are Trading Higher Today
Generation Bio (NASDAQ: GBIO) shares are trading higher on Thursday after the company and Moderna (NASDAQ: MRNA) announced a collaboration to develop non-viral genetic medicines.
Why Is Duluth Stock Trading Higher Today?
Duluth (NASDAQ: DLTH) shares are trading higher on Thursday after the company reported better-than-expected Q4 EPS results.
Why Assertio Therapeutics Shares Are Trading Higher Today
Assertio Therapeutics (NASDAQ: ASRT) shares are trading higher on Thursday after the company reported better-than-expected Q4 sales results.
Why Kimball International Shares Are Trading Higher Today
Kimball International (NASDAQ: KBAL) shares are trading higher on Wednesday after HNI Corporation announced it will acquire the company for $485 million.
Why Diversey Shares Are Trading Higher Today
Diversey (NASDAQ: DSEY) shares are trading higher on Wednesday after the company announced it will be acquired by Solenis for $4.6 billion in an all-cash transaction.
Why Is AeroVironment Stock Trading Higher Today?
AeroVironment (NASDAQ: AVAV) shares are trading higher on Tuesday after the company reported better-than-expected Q3 revenues. Multiple analysts raised their price targets on the stock.
Why Nutanix Shares Are Trading Lower Today
Nutanix (NASDAQ: NTNX) shares are trading lower on Tuesday after the company said its second-quarter results were not audited due to an investigation related to third-party evaluation software and it does not expect to be able to file its 10-Q on time.
Why Vistra Shares Are Trading Higher Today
Vistra (NYSE: VST) shares are trading higher on Tuesday after the company announced an agreement with Energy Harbor, under which Energy Harbor will merge with and into a newly-formed subsidiary called Vistra Vision.
Why Azul Stock Is Flying High Today
Azul S.A. (NYSE: AZUL) shares are trading higher on Monday after the company announced a deal to reduce the immediate cash it must expend for leased property.
Why Is TCR2 Therapeutics Stock Trading Higher Today?
TCR² Therapeutics (NASDAQ: TCRR) shares are trading higher on Monday after the company and Adaptimmune Therapeutics (NASDAQ: ADAP) announced an agreement under which the two companies will combine to create a cell